In contrast, when treatment must be initiated for aggressive lymphoma, it will be based on chemotherapy in combination with immunotherapy. The chemotherapy will often be a combination of agents, administered through intravenous from an implantable chamber. In Hodgkin’s lymphoma, it is not uncommon to combine radiation therapy, which uses ionizing radiation to destroy the cancer cells, after 3 or 4 cycles of chemotherapy. In the case of relapse, management is evolving with more and more options based on immunotherapy and targeted therapy, although chemotherapy followed by autotransplantation is still an option in the first relapse.